Status:
RECRUITING
MBRP on Reducing Craving and Addictive Behaviour in Adults
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Substance Abuse
Substance Use Disorders
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Mindfulness-base interventions are promising interventions as an adjunctive therapy to be integrated into current existing anti-drug services. The advantages of MBRP can include: 1) having very low st...
Detailed Description
Overall Study Design This is a feasibility study and it is a single-blinded, randomized controlled trial with two study arms: the mindfulness-based relapse prevention (MBRP) programme led by trained m...
Eligibility Criteria
Inclusion
- Fluent in Cantonese;
- Has ever fulfilled the Structured Clinical Interview for DSM-IV/DSM-5 (SCID) drug module criteria for substance use disorder diagnoses; and
- Has completed outpatient or inpatient treatment for substance abuse in the previous 6 months.
Exclusion
- Inability to provide valid consent;
- Current or lifetime psychotic disorder assessed by the Structured Clinical interview for DSM-IV/DSM-5;
- Imminent suicidal risk; or
- Dementia.
Key Trial Info
Start Date :
August 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04034732
Start Date
August 15 2019
End Date
August 31 2024
Last Update
February 7 2024
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Psychiatry, AHNH, Hospital Authority
Hong Kong, Hong Kong
2
Department of Psychiatry, NDH, Hospital Authority
Hong Kong, Hong Kong
3
Evergreen Lutheran Centre, Hong Kong Lutheran Social Service
Hong Kong, Hong Kong
4
Neo-Health Group
Hong Kong, Hong Kong